Journal: Research
Article Title: NUFIP1-Mediated Ribophagy Alleviates PANoptosis of CD4 + T Lymphocytes in Sepsis via the cGAS-STING Pathway
doi: 10.34133/research.0895
Figure Lengend Snippet: Impact of conditional deletion of NUFIP1 on immune response of CD4 + T lymphocytes, organ injury, and the 1-week survival rate of mice in sepsis. (A) The proliferative activity of splenic CD4 + T cells was measured by CCK-8 after CLP operation. n = 3 technical repetitions. (B) Serum cytokine levels in the Flox and cKO groups were measured by ELISA after CLP operation. n = 4 technical repetitions. (C and E) Proportion of CD3 + T lymphocytes in the peripheral blood of mice in different groups detected by flow cytometry. n = 3 technical repetitions. (D and F) The proportion of CD3 + CD4 + T lymphocytes in the peripheral blood of mice in different groups was detected by flow cytometry. n = 3 technical repetitions. (G and H) The ratio of Th1/Th2 of splenic CD4 + T cells was detected by flow cytometry. n = 3 technical repetitions. (I and J) Percentage of Tregs of splenic CD4 + T cells detected by flow cytometry. n = 3 technical repetitions. (K and L) Percentage of Th17 cells of splenic CD4 + T cells detected by flow cytometry. n = 3 technical repetitions. (M to Q) H&E staining assessment of various organ lesions, including heart (M), lung (N), liver (O), and kidney (P) in different groups of mice. The scale bar represents 50 μm. n = 3 biological independent samples. (R) One-week survival curves of different groups of mice (** P < 0.01 compared with the sham group; # P < 0.05 compared with the Flox-CLP group). n = 10 biological independent samples. Data were expressed as means ± SEM. A 2-way ANOVA test was applied to test the statistical significance. * P < 0.05, ** P < 0.01, *** P < 0.001 compared with the Flox group. ## P < 0.01, ### P < 0.001 compared with the cKO-sham group.
Article Snippet: CD4 + T lymphocyte-specific NUFIP1 cKO mice ( Cd4 cre Nufip1 fl/fl ) and their corresponding control mice ( Nufip1 fl/fl ) were generated and raised to 6 to 8 weeks of age by Cyagen Biosciences Inc. (Suzhou, Jiangsu, China).
Techniques: Activity Assay, CCK-8 Assay, Enzyme-linked Immunosorbent Assay, Flow Cytometry, Staining